Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915213 · ClinicalTrials.gov registry record
Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy
A clinical trial of Bacterial Infection, sponsored by University of California, Irvine.
- Completed
- Registry status
- 136
- Enrollment target
- 3
- Study locations
NCT00915213: Completed study of Bacterial Infection, sponsored by University of California, Irvine.
NCT00915213 is a study of Bacterial Infection that has completed, run by University of California, Irvine. The registered enrollment target is 136 participants, above the 88-participant average among 8 other Bacterial Infection trials with a reported enrollment target (55% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00915213, a study of Bacterial Infection, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bacteria from causing infection are no longer effective. Many physicians around the world are noting increased infections with antibiotic resistant bacteria. Therefore; despite treating patients who are to undergo prostate biopsy with antibiotics, certain patients are being readmitted to the hospital with a serious infection. In order to study the incidence of these particular bacteria, the best method is to culture the bacteria at the time of the biopsy. This involves one rectal culture swab just prior to needle biopsy of the prostate. Once the incidence of these bacteria is known we may take steps to prevent the serious infections that occur as a result of prostate biopsy.
Conditions Studied
Study Locations (3)
California
- Kaiser Permanente - Irvine
- Long Beach Veteran Affairs - Long Beach
- University of California, Irvine Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-12 |
What the finished NCT00915213 record still lists
NCT00915213 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, above the 88-participant average among 8 other Bacterial Infection trials with a reported enrollment target (55% higher).
The record links to 1 condition, with Bacterial Infection appearing as the primary indexed condition, and to 0 interventions.
NCT00915213 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00915213 about?
NCT00915213 is a clinical study titled "Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy". The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bact...
What is the current status of trial NCT00915213?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2008-10. Estimated completion is 2014-12.
What conditions does trial NCT00915213 study?
This clinical trial studies the following conditions: Bacterial Infection.
Who is sponsoring clinical trial NCT00915213?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00915213 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00915213's enrollment target sits among peer trials
136 4th of 8 higher than 5 of 8 other Bacterial Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bacterial Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
RECRUITING · Phase 4
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
COMPLETED · Phase 2
-
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
COMPLETED · NA
-
Safety of Intravenous Apramycin in Adults
COMPLETED · Phase 1
-
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia